MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors
Bone Reports
· Elsevier
Аннотация у издателя не опубликована — полный текст доступен по ссылке ниже.
Читать у издателя →
Цитирование
MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors. // Bone Reports. – URL: https://www.sciencedirect.com/science/article/pii/S2352187226000380?dgcid=rss_sd_all
MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors. Bone Reports. https://www.sciencedirect.com/science/article/pii/S2352187226000380?dgcid=rss_sd_all
“MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors.” Bone Reports.
@article{article38882,
title = {MRONJ risk associated with combined antiresorptive and vascular endothelial growth factor receptor tyrosine kinase inhibitors},
journal = {Bone Reports},
url = {https://www.sciencedirect.com/science/article/pii/S2352187226000380?dgcid=rss_sd_all}
}